449 related articles for article (PubMed ID: 16809740)
41. Early-life sun exposure and risk of melanoma before age 40 years.
Cust AE; Jenkins MA; Goumas C; Armstrong BK; Schmid H; Aitken JF; Giles GG; Kefford RF; Hopper JL; Mann GJ
Cancer Causes Control; 2011 Jun; 22(6):885-97. PubMed ID: 21472378
[TBL] [Abstract][Full Text] [Related]
42. [Malignant melanoma--a warning. How to reduce mortality?].
Volden G; Rajka G; Thune P; Falk ES; Krogh HK
Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1202-5. PubMed ID: 2333644
[TBL] [Abstract][Full Text] [Related]
43. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
44. The simultaneous assessment of constitutional, behavioral, and environmental factors in the development of large nevi.
Cockburn M; Hamilton A; Mack T
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):200-6. PubMed ID: 17267390
[TBL] [Abstract][Full Text] [Related]
45. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma.
Autier P; Boniol M; Severi G; Pedeux R; Grivegnée AR; Doré JF
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2003-5. PubMed ID: 15598754
[TBL] [Abstract][Full Text] [Related]
46. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
[TBL] [Abstract][Full Text] [Related]
47. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
Briollais L; Chompret A; Guilloud-Bataille M; Bressac-de Paillerets B; Avril MF; Demenais F
Int J Epidemiol; 2000 Jun; 29(3):408-15. PubMed ID: 10869311
[TBL] [Abstract][Full Text] [Related]
48. Tanning bed exposure increases the risk of malignant melanoma.
Ting W; Schultz K; Cac NN; Peterson M; Walling HW
Int J Dermatol; 2007 Dec; 46(12):1253-7. PubMed ID: 18173518
[TBL] [Abstract][Full Text] [Related]
49. The association between residential pesticide use and cutaneous melanoma.
Fortes C; Mastroeni S; Melchi F; Pilla MA; Alotto M; Antonelli G; Camaione D; Bolli S; Luchetti E; Pasquini P
Eur J Cancer; 2007 Apr; 43(6):1066-75. PubMed ID: 17331713
[TBL] [Abstract][Full Text] [Related]
50. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.
Anderson WF; Pfeiffer RM; Tucker MA; Rosenberg PS
Cancer; 2009 Sep; 115(18):4176-85. PubMed ID: 19536874
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types.
Holman CD; Armstrong BK
J Natl Cancer Inst; 1984 Jul; 73(1):75-82. PubMed ID: 6588237
[TBL] [Abstract][Full Text] [Related]
52. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals.
Nelemans PJ; Groenendal H; Kiemeney LA; Rampen FH; Ruiter DJ; Verbeek AL
Environ Health Perspect; 1993 Aug; 101(3):252-5. PubMed ID: 8404764
[TBL] [Abstract][Full Text] [Related]
53. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
54. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
55. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
[TBL] [Abstract][Full Text] [Related]
56. Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients.
Micu E; Baturaite Z; Juzeniene A; Bruland ØS; Moan JE
Melanoma Res; 2012 Dec; 22(6):460-5. PubMed ID: 23010822
[TBL] [Abstract][Full Text] [Related]
57. Role of sun exposure in melanoma.
Ivry GB; Ogle CA; Shim EK
Dermatol Surg; 2006 Apr; 32(4):481-92. PubMed ID: 16681655
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for malignant melanoma in an Icelandic population sample.
Rafnsson V; Hrafnkelsson J; Tulinius H; Sigurgeirsson B; Olafsson JH
Prev Med; 2004 Aug; 39(2):247-52. PubMed ID: 15226032
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.
Kvaskoff M; Siskind V; Green AC
Arch Dermatol; 2012 Feb; 148(2):164-70. PubMed ID: 22004881
[TBL] [Abstract][Full Text] [Related]
60. Risk of melanoma following adulthood cancer: a case-control study.
Dupuy A; Shamsaldin A; Quiniou E; Paoletti C; Labbé M; Avril MF; Lefkopoulos D; de Vathaire F
Eur J Cancer; 2005 Dec; 41(18):2904-10. PubMed ID: 16243516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]